Blocking cancer-fibroblast mutualism inhibits proliferation of endocrine therapy resistant breast cancer
Abstract In early-stage estrogen receptor-positive (ER + ) breast cancer, resistance to endocrine therapy (ET) and CDK4/6 inhibitors (CDK4/6i) often involve a shift away from estrogen-driven proliferation. The nature and source of compensatory growth signals driving cancer proliferation remain unkno...
Saved in:
| Main Authors: | Jason I Griffiths, Feng Chi, Elena Farmaki, Eric F Medina, Patrick A Cosgrove, Kimya L Karimi, Jinfeng Chen, Vince K Grolmusz, Frederick R Adler, Qamar J Khan, Aritro Nath, Jeffrey T Chang, Andrea H Bild |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2025-05-01
|
| Series: | Molecular Systems Biology |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s44320-025-00104-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ENDORSE: a prognostic model for endocrine therapy in estrogen‐receptor‐positive breast cancers
by: Aritro Nath, et al.
Published: (2022-06-01) -
Mutual insurance risks
by: L. A. Orlanyuk–Malitskaya
Published: (2024-07-01) -
Cellular interactions within the immune microenvironment underpins resistance to cell cycle inhibition in breast cancers
by: Jason I. Griffiths, et al.
Published: (2025-03-01) -
Current feasibility of endocrine therapy for breast cancer
by: I. V. Vysotskaya
Published: (2014-07-01) -
Plasma Level’s of Neuregulin-1 in Healthy People
by: K. A. Zhbanov, et al.
Published: (2022-01-01)